kavin submitted, created time 6 months 2 days (www.scidev.net)

Government support, strong leadership within institutions and the protection of "genomic sovereignty" are vital to the burgeoning genomic medicine sector in developing countries, say researchers.

Some developing countries are starting to use genomic science, aiming both for public health benefits and to produce knowledge to stimulate their economies. They often do this by setting up large-scale genotyping projects to assess susceptibility to disease

Submit comment | Blog It | Email It | Keywords: politics genomics genomic medicine NIH National Institutes of Health public health care developing nations developing countries genetic diseases